Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling. [electronic resource] by
- Davit, B
- Reynolds, K
- Yuan, R
- Ajayi, F
- Conner, D
- Fadiran, E
- Gillespie, B
- Sahajwalla, C
- Huang, S M
- Lesko, L J
Producer: 19991101
In:
Journal of clinical pharmacology vol. 39
Availability: No items available.
|
|
14.
|
Population pharmacokinetics. A regulatory perspective. [electronic resource] by
- Sun, H
- Fadiran, E O
- Jones, C D
- Lesko, L
- Huang, S M
- Higgins, K
- Hu, C
- Machado, S
- Maldonado, S
- Williams, R
- Hossain, M
- Ette, E I
Producer: 19991005
In:
Clinical pharmacokinetics vol. 37
Availability: No items available.
|